Photodynamic therapy: An option in mycosis fungoides

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 641 citations · Full text

Immunodeficiencies, Immunology, Clinical End Points +17

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation

Katarina Svanberg, Tommy Andersson, D. Killander et al. · British Journal of Dermatology · 1994 · 427 citations

THE ROLE OF TRANSFERRIN RECEPTOR (CD71) IN PHOTODYNAMIC THERAPY OF ACTIVATED AND MALIGNANT LYMPHOCYTES USING THE HEME PRECURSOR δ‐AMINOLEVULINIC ACID (ALA)

Henricus van Leengoed, Janet Morgan, Eric A. Hryhorenko et al. · Photochemistry and Photobiology · 1995 · 127 citations

Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid

Peter Wolf, Regina Fink‐Puches, Lorenzo Cerroni et al. · Journal of the American Academy of Dermatology · 1994 · 114 citations

Allergy, Photochemistry, Photodynamic Therapy +10

Photodynamic Therapy with Topical 5-Aminolevulinic Acid for Mycosis Fungoides: Clinical and Histological Response

Anna Porwi Desiree Wiegleb Edström · Acta Dermato Venereologica · 2001 · 80 citations · Full text

Immunology, Pathology, Dermatology +18